Dr. Gaggar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
303 Velocity Way
Foster City, CA 94404
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2008 - 2011- University of California (San Francisco)Residency, Internal Medicine, 2006 - 2010
University of Washington School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2014
Clinical Trials
Publications & Presentations
PubMed
- 125 citationsEffects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus...Henry Lik-Yuen Chan, Chi Kuen Chan, Aric J. Hui, Sing Chan, Fred Poordad
Gastroenterology. 2014-05-01 - 39 citationsCOVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation.Michael John Patton, Carlos J Orihuela, Kevin S Harrod, Mohammad A N Bhuiyan, Paari Dominic
Critical Care. 2023-01-23 - 842 citationsEffect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.Christoph D. Spinner, Robert L. Gottlieb, Gerard J. Criner, José Ramón Arribas López, Anna Maria Cattelan
JAMA. 2020-09-15
Journal Articles
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19Robert L Gottlieb, Gerard J Criner, Onyema Ogbuagu, Kathleen M Mullane, Anuj Gaggar, Diana M Brainard, Gregory Huhn, JAMA
Authored Content
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Join now to see all
Press Mentions
Trial Finds Drug Safe and Effective in Treating Hep-C During PregnancyJuly 28th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
